Compare Edwards Lifesciences Corporation Common Stock (EW) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 3.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | HALO | |
|---|---|---|
Market Cap | $48.56B | $12.58B |
Volume | 6,520,488 | 2,179,278 |
Sector | Health | Health |
52-Week High | $95.18 | $115.22 |
52-Week Low | $72.65 | $61.63 |
Enterprise Value | $45.01B | $14.49B |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
